C12N 2330/00
Production
C12N2330/00 (Production) appears on 1,299 US grants and 2,553 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,299
- Published applications
- 2,553
- Assignees
- 905
- Inventors
- 3,975
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 3 | 6 |
| 2003 | 4 | 25 |
| 2004 | 1 | 53 |
| 2005 | 2 | 110 |
| 2006 | 5 | 70 |
| 2007 | 7 | 66 |
| 2008 | 9 | 67 |
| 2009 | 20 | 113 |
| 2010 | 45 | 102 |
| 2011 | 46 | 93 |
| 2012 | 60 | 110 |
| 2013 | 68 | 108 |
| 2014 | 81 | 115 |
| 2015 | 87 | 124 |
| 2016 | 75 | 143 |
| 2017 | 79 | 129 |
| 2018 | 104 | 151 |
| 2019 | 96 | 158 |
| 2020 | 84 | 133 |
| 2021 | 87 | 126 |
| 2022 | 72 | 140 |
| 2023 | 69 | 129 |
| 2024 | 71 | 121 |
| 2025 | 64 | 97 |
| 2026 | 55 | 63 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Vectors and compositions for treating hemoglobinopathies11 Aug 2026US 12,703,864 B2Children's Medical Center Corporation
- Viral vectors for treating Parkinson's disease4 Aug 2026US 12,697,360 B2American Gene Technologies International Inc.
- RAAV-based compositions and methods for treating amyotrophic lateral sclerosis23 Jun 2026US 12,662,669 B2University of Massachusetts
- Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers16 Jun 2026US 12,653,851 B2Hangzhou Converd Co., Ltd.
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Biological libraries and methods of preparing and using same8 Oct 2026US 2026/0308575 A1
- Novel internal ribosome entry site (ires) and intron sequences1 Oct 2026US 2026/0297579 A1Ginkgo Bioworks, Inc.
- Analytical device for real time luminescence during temperature hold and ramp as used in real time cellular thermal shift assay1 Oct 2026US 2026/0297593 A1The United States of America, as represented by the Secretary, Department of Health and Human Serv
- Intraluminal stents for treating benign prostatic hyperplasia1 Oct 2026US 2026/0297612 A1Rivermark Medical, Inc.
- Host cell for improving stability of plasmid10 Sep 2026US 2026/0265764 A1Nanjing GenScript Biotech Co., Ltd.
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- RNA interference mediating small RNA molecules382US 7,056,704 B2MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V · 2006
- RNA interference mediating small RNA molecules333US 7,078,196 B2MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V · 2006
- In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom267US 5,624,803 AThe Regents of the University of California · 1997
- Modulation of apolipoprotein C-III expression262US 7,598,227 B2Isis Pharmaceuticals, Inc. · 2009